Shape Therapeutics, a Seattle preclinical stage biotech company developing RNA editing and gene therapy technologies, has raised $112 million. The… Read More
Juno Therapeutics, the Seattle-based biotech company making cutting-edge cancer immunotherapy treatments, has reached a deal to be acquired by New Jersey-based… Read More
Longtime Seattle tech design leader Hillel Cooperman has joined Oracle as the company’s senior vice president of user experience and design,… Read More
Juno Therapeutics, the Seattle-based biotech company developing immunotherapy cancer treatments, unveiled promising new data from a study on its flagship… Read More
Seattle’s Juno Therapeutics, a biotech company developing cutting edge CAR T immunotherapies for cancer, faces a narrow field of competitors. Few… Read More
Seattle-based biotech company Juno Therapeutics beat analyst expectations in its second quarter revenue Thursday, reporting $21.3 million in revenue for… Read More
Seattle-based biotech juggernaut Juno Therapeutics delivered mixed results in its 2017 quarter one earnings report Thursday — the first financial report… Read More
